Shares of Danish pharmaceutical giant Novo Nordisk plummeted more than 22% on Friday after reporting results in a late-stage trial that missed expectations.
Related Posts
Zelensky accuses EU allies of ‘blackmail’ in oil pipeline row
Volodymyr Zelensky says restoring the flow of Russian oil via Ukraine into the EU would be like lifting sanctions on…
2024 first year to pass 1.5C global warming limit
Last year was the world’s warmest on record, bringing temperatures above a politically symbolic milestone.
China’s DeepSeek launches next-gen AI model. Here’s what makes it different
The Chinese artificial intelligence startup has now released DeepSeek-V3.2-Exp, an experimental version of its current model DeepSeek-V3.1-Terminus.